Predictors and prevention of diabetic cardiomyopathy
Authors:
- Paras MishraParas Mishra
- Suresh C TyagiSTSuresh C Tyagi
Open Access
- 1 April 2013
- journal article
- review article
- Published by Taylor & Francis in Diabetes, Metabolic Syndrome and Obesity
- Vol. ume 6, 151-160
Abstract
Despite our cognizance that diabetes can enhance the chances of heart failure, causes multiorgan failure,and contributes to morbidity and mortality, it is rapidly increasing menace worldwide. Less attention has been paid to alert prediabetics through determining the comprehensive predictors of diabetic cardiomyopathy (DCM) and ameliorating DCM using novel approaches. DCM is recognized as asymptomatic progressing structural and functional remodeling in the heart of diabetics, in the absence of coronary atherosclerosis and hypertension. The three major stages of DCM are: (1) early stage, where cellular and metabolic changes occur without obvious systolic dysfunction; (2) middle stage, which is characterized by increased apoptosis, a slight increase in left ventricular size, and diastolic dysfunction and where ejection fraction (EF) is <50%; and (3) late stage, which is characterized by alteration in microvasculature compliance, an increase in left ventricular size, and a decrease in cardiac performance leading to heart failure. Recent investigations have revealed that DCM is multifactorial in nature and cellular, molecular, and metabolic perturbations predisposed and contributed to DCM. Differential expression of microRNA (miRNA), signaling molecules involved in glucose metabolism, hyperlipidemia, advanced glycogen end products, cardiac extracellular matrix remodeling, and alteration in survival and differentiation of resident cardiac stem cells are manifested in DCM. A sedentary lifestyle and high fat diet causes obesity and this leads to type 2 diabetes and DCM. However, exercise training improves insulin sensitivity, contractility of cardiomyocytes, and cardiac performance in type 2 diabetes. These findings provide new clues to diagnose and mitigate DCM. This review embodies developments in the field of DCM with the aim of elucidating the future perspectives of predictors and prevention of DCM.Keywords
This publication has 120 references indexed in Scilit:
- Prediabetes: a high-risk state for diabetes developmentThe Lancet, 2012
- Diabetic cardiomyopathy: pathophysiology and clinical featuresHeart Failure Reviews, 2012
- Markers of Inflammation, Metabolic Risk Factors, and Incident Heart Failure in American Indians: The Strong Heart StudyThe Journal of Clinical Hypertension, 2011
- MicroRNA Involvement in Immune Activation During Heart FailureCardiovascular Drugs and Therapy, 2011
- Attenuation of beta2-adrenergic receptors and homocysteine metabolic enzymes cause diabetic cardiomyopathyBiochemical and Biophysical Research Communications, 2010
- MMP-9 Gene Ablation and TIMP-4 Mitigate PAR-1-Mediated Cardiomyocyte Dysfunction: A Plausible Role of Dicer and miRNACell Biochemistry and Biophysics, 2010
- Diagnostic approaches for diabetic cardiomyopathy and myocardial fibrosisJournal of Molecular and Cellular Cardiology, 2010
- Diabetic cardiomyopathy, causes and effectsReviews in Endocrine and Metabolic Disorders, 2010
- MicroRNAs: Target Recognition and Regulatory FunctionsCell, 2009
- The Tumor Suppressor Gene PTEN Can Regulate Cardiac Hypertrophy and SurvivalJournal of Biological Chemistry, 2001